4//SEC Filing
Sheehy Douglas T. 4
Accession 0000899243-20-027458
CIK 0001631650other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 9:14 PM ET
Size
8.1 KB
Accession
0000899243-20-027458
Insider Transaction Report
Form 4
Sheehy Douglas T.
See Remarks
Transactions
- Exercise/Conversion
Common Stock, $0.0001 par value
2020-10-05$12.95/sh+30,888$400,000→ 85,426 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-10-05−30,888→ 22,361 totalExercise: $12.95Exp: 2026-04-29→ Common Stock (30,888 underlying)
Footnotes (4)
- [F1]Includes 11,250 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in three successive, equal, annual installments measured from March 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F2]Includes 9,375 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F3]Includes 21,492 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F4]Fully exercisable.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001488637
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 9:14 PM ET
- Size
- 8.1 KB